These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30443840)

  • 21. The antihypertensive effectiveness and safety of dual RAAS blockade with aliskiren and valsartan.
    Chrysant SG
    Drugs Today (Barc); 2010 Mar; 46(3):151-62. PubMed ID: 20467589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain.
    Wagner J; Drab M; Bohlender J; Amann K; Wienen W; Ganten D
    Clin Exp Hypertens; 1998 Feb; 20(2):205-21. PubMed ID: 9533614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade.
    Navar LG; Harrison-Bernard LM; Imig JD; Wang CT; Cervenka L; Mitchell KD
    J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S266-72. PubMed ID: 10201881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discordant responses to two classes of drugs acting on the renin-angiotensin system.
    Sever PS; Chang CL
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):25-30. PubMed ID: 11881062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure.
    Soldner A; Spahn-Langguth H; Mutschler E
    Pharmazie; 1996 Nov; 51(11):783-99. PubMed ID: 8985974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases.
    Rashikh A; Ahmad SJ; Pillai KK; Najmi AK
    J Pharm Pharmacol; 2012 Apr; 64(4):470-81. PubMed ID: 22420653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood Pressure Lowering and Safety Improvements With Liver Angiotensinogen Inhibition in Models of Hypertension and Kidney Injury.
    Mullick AE; Yeh ST; Graham MJ; Engelhardt JA; Prakash TP; Crooke RM
    Hypertension; 2017 Sep; 70(3):566-576. PubMed ID: 28716988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.
    Drapala A; Sikora M; Ufnal M
    J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):250-8. PubMed ID: 25037529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. K
    Poulsen SB; Fenton RA
    J Physiol; 2019 Sep; 597(17):4451-4464. PubMed ID: 31294465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease.
    Ashby EL; Kehoe PG
    Expert Opin Investig Drugs; 2013 Oct; 22(10):1229-42. PubMed ID: 23800077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative Efficacy of the Influence of Fixed Combinations of Antihypertensive Drugs That Block the Renin-Angiotensin-Aldosterone System, With Thiazide Diuretics on the Parameters of Ambulatory Blood Pressure Monitoring].
    Ostroumova OD; Garelik IA
    Kardiologiia; 2016 Dec; 56(12):20-26. PubMed ID: 28290800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system.
    Gammelgaard I; Wamberg S; Bie P
    Acta Physiol (Oxf); 2006 Oct; 188(2):129-38. PubMed ID: 16948800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies.
    Patel S; Rauf A; Khan H; Abu-Izneid T
    Biomed Pharmacother; 2017 Oct; 94():317-325. PubMed ID: 28772209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renin-angiotensin-aldosterone system blockade in high-risk hypertensive patients: current approaches and future trends.
    Gullapalli N; Bloch MJ; Basile J
    Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):359-73. PubMed ID: 20965951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
    Aulakh GK; Sodhi RK; Singh M
    Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions.
    Angeli F; Reboldi G; Mazzotta G; Poltronieri C; Garofoli M; Ramundo E; Biadetti A; Verdecchia P
    Curr Drug Saf; 2012 Feb; 7(1):76-85. PubMed ID: 22663961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renin-angiotensin system in the antihypertensive effect of isoteoline in spontaneously hypertensive rats.
    Markov M; Higashino H; Suzuki A
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S368-70. PubMed ID: 9072431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.